Welcome to our dedicated page for ACME UNITED SEC filings (Ticker: ACU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Acme United Corporation filings document the formal disclosures of an operating company that supplies first aid and medical products, safety solutions and cutting technology. Its 8-K reports include operating and financial results, material-event disclosures, acquisition-related reporting, credit-facility matters and other corporate updates affecting the company's capital and operating structure.
ACU proxy and annual-meeting filings cover board elections, executive compensation votes, equity incentive plan amendments and auditor ratification. The company's regulatory record also includes material agreement disclosures, including amendments to its secured revolving credit facility, along with governance matters and shareholder voting results.
Susan H. Murphy, a director of Acme United Corp (ACU), exercised an employee stock option on 08/12/2025 to acquire 2,500 shares at an exercise price of $43.40 per share. The options became exercisable on 08/13/2025 and expire 08/12/2035. Following the transaction, Ms. Murphy beneficially owns 29,000 shares on a direct basis. The Form 4 was signed 08/14/2025 and reports the change required under Section 16.
ACU Q2-25 10-Q highlights:
- Revenue: Q2 net sales $54.0 M, -3% YoY; 6-mo $100.0 M, flat YoY.
- Profitability: Q2 gross margin 41.0% (40.8% LY); operating income $6.4 M (flat); net income $4.8 M, +7% YoY; diluted EPS $1.16 vs $1.09. 6-mo net income $6.4 M, +5%; diluted EPS $1.57 vs $1.47.
- Segment trends: U.S. sales -5% on tariff-driven back-to-school order cancellations; Canada +28% on first-aid demand; Europe -3% (shipment delays).
- Cash & liquidity: Operating cash inflow $3.0 M vs $-3.3 M LY; capex $3.0 M. Cash $3.6 M; revolver borrowings $16.4 M (-$1.3 M YTD); mortgage $10.2 M; long-term-debt-to-equity 22.9%.
- Balance sheet: Working capital $77.9 M; current ratio 4.3x. Inventory $57.3 M, turnover unchanged at 2.1x.
- Credit facility: $65 M HSBC revolver maturity extended to 5/31/27 at SOFR +1.75%.
- Controls: Material weakness in IT general controls persists; remediation expected by YE-25.
- Outlook drivers: tariff volatility, supply-chain diversification, demand seasonality (back-to-school), ongoing integration of Elite First Aid (no new financial impact disclosed).